| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.25 | 0.0001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.1 | 0.08 |